Annovis Bio (ANVS)

• Market cap: $75M
• 1 day: 12.3%
• 5 days: 8.02%
• 1 month: 18.91%
• 3 months: -27.99%
• 6 months: 19.41%
• Year to date: -22.47%
• 1 year: 46.63%
• 5 years: -91.5%
• 10 years: -70.49%
• Sector: Healthcare
• Industry: Biotechnology

About: Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Employees: 6